Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety,

PepGen has set aside another $45 million to take PGN-EDODM1 through a phase 1/2 clinical trial. The drug candidate is designed for use in DMD patients …, PepGen has set aside another $45 million to take PGN-EDODM1 through a phase 1/2 clinical trial. The drug candidate is designed for use in DMD patients …, Read More

Scroll to Top